Funder: Food and Drug Administration

Due Dates: Forecasted; estimated post and due dates not yet announced

Funding Amounts: Number of awards: 2 (award size not specified); cooperative agreement

Summary: Supports applied regulatory science research to improve detection, monitoring, and treatment of cardiotoxicity from oncology therapeutics, with direct FDA collaboration.

Key Information: FDA will be actively involved in study design and progress; regular calls with funded investigators are expected.